Works matching IS 03407004 AND DT 2024 AND VI 73 AND IP 11
Results: 26
Correction to: Inhibition of glycolysis enhances the efficacy of immunotherapy via PDK‑mediated upregulation of PD‑L1.
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice
Bronchoalveolar lavage fluid analysis in patients with checkpoint inhibitor pneumonitis.
- Published in:
- Cancer Immunology, Immunotherapy, 2024, v. 73, n. 11, p. 1, doi. 10.1007/s00262-024-03834-y
- By:
- Publication type:
- Article
Genomic and molecular alterations associated with primary resistance to immune checkpoint inhibitors.
- Published in:
- Cancer Immunology, Immunotherapy, 2024, v. 73, n. 11, p. 1, doi. 10.1007/s00262-024-03825-z
- By:
- Publication type:
- Article
Single-cell RNA sequencing to map tumor heterogeneity in gastric carcinogenesis paving roads to individualized therapy.
- Published in:
- Cancer Immunology, Immunotherapy, 2024, v. 73, n. 11, p. 1, doi. 10.1007/s00262-024-03820-4
- By:
- Publication type:
- Article
A monoclonal antibody recognizing CD98 on human embryonic stem cells shows anti-tumor activity in hepatocellular carcinoma xenografts.
- Published in:
- Cancer Immunology, Immunotherapy, 2024, v. 73, n. 11, p. 1, doi. 10.1007/s00262-024-03827-x
- By:
- Publication type:
- Article
Recent clinical researches and technological development in TIL therapy.
- Published in:
- Cancer Immunology, Immunotherapy, 2024, v. 73, n. 11, p. 1, doi. 10.1007/s00262-024-03793-4
- By:
- Publication type:
- Article
Adjuvant chemoradiotherapy plus pembrolizumab for locally advanced esophageal squamous cell carcinoma with high risk of recurrence following neoadjuvant chemoradiotherapy: a single-arm phase II study.
- Published in:
- Cancer Immunology, Immunotherapy, 2024, v. 73, n. 11, p. 1, doi. 10.1007/s00262-024-03826-y
- By:
- Publication type:
- Article
Disruptions in antigen processing and presentation machinery on sarcoma.
- Published in:
- Cancer Immunology, Immunotherapy, 2024, v. 73, n. 11, p. 1, doi. 10.1007/s00262-024-03822-2
- By:
- Publication type:
- Article
Adding-on nivolumab to chemotherapy-stabilized patients is associated with improved survival in advanced pancreatic ductal adenocarcinoma.
- Published in:
- Cancer Immunology, Immunotherapy, 2024, v. 73, n. 11, p. 1, doi. 10.1007/s00262-024-03821-3
- By:
- Publication type:
- Article
Secretome and immune cell attraction analysis of head and neck cancers.
- Published in:
- Cancer Immunology, Immunotherapy, 2024, v. 73, n. 11, p. 1, doi. 10.1007/s00262-024-03809-z
- By:
- Publication type:
- Article
Oncolytic virotherapy augments self-maintaining natural killer cell line cytotoxicity against neuroblastoma.
- Published in:
- Cancer Immunology, Immunotherapy, 2024, v. 73, n. 11, p. 1, doi. 10.1007/s00262-024-03818-y
- By:
- Publication type:
- Article
Correction to: Impact of fludarabine and treosulfan on ovarian tumor cells and mesothelin chimeric antigen receptor T cells.
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice
A comprehensive and longitudinal evaluation of the different populations of lymphoid and myeloid cells in the peripheral blood of patients treated with chemoradiotherapy for head and neck cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2024, v. 73, n. 11, p. 1, doi. 10.1007/s00262-024-03810-6
- By:
- Publication type:
- Article
Immunogenomic features of radiologically distinctive nodules in multiple primary lung cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2024, v. 73, n. 11, p. 1, doi. 10.1007/s00262-024-03807-1
- By:
- Publication type:
- Article
High proportion of PD-1 and CD39 positive CD8+ tissue resident T lymphocytes correlates with better clinical outcome in resected human oesophageal adenocarcinoma.
- Published in:
- Cancer Immunology, Immunotherapy, 2024, v. 73, n. 11, p. 1, doi. 10.1007/s00262-024-03799-y
- By:
- Publication type:
- Article
Immune microenvironmental heterogeneity according to tumor DNA methylation phenotypes in microsatellite instability-high colorectal cancers.
- Published in:
- Cancer Immunology, Immunotherapy, 2024, v. 73, n. 11, p. 1, doi. 10.1007/s00262-024-03805-3
- By:
- Publication type:
- Article
Stat3-mediated Atg7 expression regulates anti-tumor immunity in mouse melanoma.
- Published in:
- Cancer Immunology, Immunotherapy, 2024, v. 73, n. 11, p. 1, doi. 10.1007/s00262-024-03804-4
- By:
- Publication type:
- Article
The short-term efficacy of neoadjuvant SOX versus SOX plus immune checkpoint inhibitor following laparoscopic gastrectomy for locally advanced gastric cancer: a multicenter retrospective cohort study in China.
- Published in:
- Cancer Immunology, Immunotherapy, 2024, v. 73, n. 11, p. 1, doi. 10.1007/s00262-024-03802-6
- By:
- Publication type:
- Article
Increasing monocytes after lung cancer surgery triggers the outgrowth of distant metastases, causing recurrence.
- Published in:
- Cancer Immunology, Immunotherapy, 2024, v. 73, n. 11, p. 1, doi. 10.1007/s00262-024-03800-8
- By:
- Publication type:
- Article
SAFFRON-104: a phase Ib/II study of sitravatinib alone or with tislelizumab in advanced hepatocellular carcinoma and gastric cancer/gastroesophageal junction cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2024, v. 73, n. 11, p. 1, doi. 10.1007/s00262-024-03806-2
- By:
- Publication type:
- Article
Impaired TGF-β signaling via AHNAK family mutations elicits an esophageal cancer subtype with sensitivities to genotoxic therapy and immunotherapy.
- Published in:
- Cancer Immunology, Immunotherapy, 2024, v. 73, n. 11, p. 1, doi. 10.1007/s00262-024-03798-z
- By:
- Publication type:
- Article
Triple therapy boosts survival in NSCLC patients with brain metastases: a retrospective cohort study of chemotherapy, ICIs, and antiangiogenic agents.
- Published in:
- Cancer Immunology, Immunotherapy, 2024, v. 73, n. 11, p. 1, doi. 10.1007/s00262-024-03797-0
- By:
- Publication type:
- Article
Efficacy of durvalumab plus chemotherapy in advanced biliary duct cancer and biomarkers exploration.
- Published in:
- Cancer Immunology, Immunotherapy, 2024, v. 73, n. 11, p. 1, doi. 10.1007/s00262-024-03796-1
- By:
- Publication type:
- Article
Outcome of immune checkpoint inhibitor treatment in non-small cell lung cancer patients with interstitial lung abnormalities: clinical utility of subcategorizing interstitial lung abnormalities.
- Published in:
- Cancer Immunology, Immunotherapy, 2024, v. 73, n. 11, p. 1, doi. 10.1007/s00262-024-03792-5
- By:
- Publication type:
- Article
Distribution characteristics of immune infiltration and lymphovascular invasion in patients with breast cancer skin recurrence.
- Published in:
- Cancer Immunology, Immunotherapy, 2024, v. 73, n. 11, p. 1, doi. 10.1007/s00262-024-03783-6
- By:
- Publication type:
- Article
Characterization of pre- and on-treatment soluble immune mediators and the tumor microenvironment in NSCLC patients receiving PD-1/L1 inhibitor monotherapy.
- Published in:
- Cancer Immunology, Immunotherapy, 2024, v. 73, n. 11, p. 1, doi. 10.1007/s00262-024-03781-8
- By:
- Publication type:
- Article